**UNITED        STATES**

**SECURITIES        AND EXCHANGE COMMISSION**

**Washington,        D.C. 20549**

**FORM        10-QSB**

| [X]                  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES                  EXCHANGE ACT OF 1934 |
|-------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                          | For                  the quarterly period ended December 31,                  2004 |

| [                  ]                  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES                  EXCHANGE ACT OF 1934 |
|-------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                            | For                  the transition period from _________to___________ |
|                                                                                                                                            | Commission                  file number: 000-29915 |

**BIO        TRACKING SECURITY, INC. **

----

| Florida                                                                                          |   | 65-0786722                                            |
|--------------------------------------------------------------------------------------------------|--------|-------------------------------------------------------|
| (State                  or other jurisdiction of incorporation or                  organization) |   | (I.R.S.                  Employer Identification No.) |

| 1                  Place Ville Marie, Suite 2821, Montreal, Quebec, Canada | H3B                  4R4    |
|----------------------------------------------------------------------------|-----------------------------|
| (Address                  of principal executive offices)                  | (Zip                  Code) |

----

**BIO        TRACKING SECURITY, INC.**

| Description | Page |
|-------------|------|

| **PART                  I. FINANCIAL INFORMATION**                                                                                                |
|---------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                              |   |   |
| Item                  1. Financial Statements (unaudited)                                                                                         |
|                                                                                                                                              |   |   |
|                                                                                                                                              | *Consolidated                  interim balance sheets at December 31, 2005                  (unaudited)* | F-1 |
|                                                                                                                                              |   |   |
|                                                                                                                                              | *Consolidated                  interim statements of operations and comprehensive income (loss)                  for the                  three months ended December 31, 2005 and 2004 and from inception to                  December 31, 2004 (unaudited)* | F-2 |
|                                                                                                                                              |   |   |
|                                                                                                                                              | *Consolidated                  interim statements of stockholders deficiency from inception to                  December                  31, 2004 (unaudited)* | F-3 |
|                                                                                                                                              |   |   |
|                                                                                                                                              | *Consolidated                  interim statements of cash flows for the three months ended December                  31, 2005 and 2004 and from inception to December 31, 2004                  (unaudited)* | F-4 |
|                                                                                                                                              |   |   |
|                                                                                                                                              | *Notes                  to consolidated condensed financial statements for the three months                  ended June 30, 2005 and 2004 (unaudited)* | F-5 |
|                                                                                                                                              |   |   |
| Item                  2. Management's Discussion and Analysis of Financial Conditions                  and                  Results of Operations | 1 |
|                                                                                                                                              |   |   |
| Item                  3. Controls and Procedures                                                                                                  | 3 |
|                                                                                                                                              |   |   |
| **PART                  II. OTHER INFORMATION**                                                                                                   |   |
|                                                                                                                                              |   |   |
| Item                  1. Legal Proceedings                                                                                                        | 4 |
|                                                                                                                                              |   |   |
| Item                  2. Unregistered Sales of Equity Securities and Use of                  Proceeds                                             | 4 |
|                                                                                                                                              |   |   |
| Item                  3. Defaults Upon Senior Securities                                                                                          | 4 |
|                                                                                                                                              |   |   |
| Item                  4. Submission of Matters to a Vote of Security Holders                                                                      | 4 |
|                                                                                                                                              |   |   |
| Item                  5. Other Information                                                                                                        | 4 |
|                                                                                                                                              |   |   |
| Item                  6. Exhibits and Reports on Form 8-K                                                                                         | 4 |
|                                                                                                                                              |   |   |
| SIGNATURES                                                                                                                                        | 5 |

----

**BIO        TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION) AND        SUBSIDIARY**

**(A        DEVELOPMENT STAGE COMPANY)**

**CONSOLIDATED        INTERIM BALANCE SHEET**

**(UNAUDITED)**

|                                                                                                                                                                                |   | **DECEMBER                    31, 2004** |          |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|------------------------------------------|---------------|
|                                                                                                                                                                                |   | **U.S.                    $**            |          |
| **ASSETS**                                                                                                                                                                          |   |                                     |          |
|                                                                                                                                                                                |   |                                     |          |
| **CURRENT                    ASSETS**                                                                                                                                               |   |                                     |          |
| Cash                                                                                                                                                                                |   |                                     | 271           |   |
| R&D                    Refundable Tax Credits                                                                                                                                   |   |                                     | 212,308       |   |
|                                                                                                                                                                                |
| Total                    Current Assets                                                                                                                                             |   |                                     | **212,579**   |   |
| Fixed                    Assets                                                                                                                                                     |   |                                     | 20,850        |   |
| Goodwill                    (Note 7)                                                                                                                                                |   |                                     | 4,762,020     |   |
|                                                                                                                                                                                |
| **Total                    Assets**                                                                                                                                                 |   |                                     | **4,995,449** |   |
|                                                                                                                                                                                |
| **LIABILITIES                    AND SHAREHOLDERS' EQUITY**                                                                                                                         |   |                                     |          |   |
|                                                                                                                                                                                |   |                                     |          |   |
| **CURRENT                    LIABILITIES**                                                                                                                                          |   |                                     |          |   |
| Accounts                    Payable                                                                                                                                                 |   |                                     | 85,000        |   |
| Due                    to Officers and Employees                                                                                                                                    |   |                                     | 98,274        |   |
|                                                                                                                                                                                |
| **Total                    Current Liabilities**                                                                                                                                    |   |                                     | **183,274**   |   |
|                                                                                                                                                                                |
| **STOCKHOLDERS'                    EQUITY:**                                                                                                                                        |   |                                     |          |   |
| Common                    stock, $.001 par value; authorized 500,000,000 shares;30,000,00                    preferred                    issued and outstanding 337,865,401 shares |   |                                     | 337,866       |   |
| Paid-in                    capital                                                                                                                                                  |   |                                     | 6,815,147     |   |
| Accumulated                    deficit during development stage                                                                                                                     |   |                                     | (2,340,838    | ) |
|                                                                                                                                                                                |
| Total                    Stockholders Equity                                                                                                                                        |   |                                     | 4,812,175     |   |
|                                                                                                                                                                                |
| **Total                    Liabilities and Stockholders' Equity**                                                                                                                   |   |                                     | **4,995,449** |   |

----

**BIO          TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION) AND          SUBSIDIARY**

**(A          DEVELOPMENT STAGE COMPANY)**

**CONSOLIDATED          INTERIM STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME          (LOSS)**

**(UNAUDITED)**

|                                                          |   | FOR                        THE PERIODOCT.                        1, 2004DECEMBER                        31, 2004 |         | FOR                        THE PERIODOCT.                        1, 2003DECEMBER                        31, 2003 |   | FOR                        THE PERIODOCT.                        19, 2000DECEMBER                        31, 2004 |   |
|---------------------------------------------------------------|--------|------------------------------------------------------------------------------------------------------------------|--------------|------------------------------------------------------------------------------------------------------------------|--------|-------------------------------------------------------------------------------------------------------------------|--------|
|                                                          |   | **U.S.$**                                                                                                        |         | **U.S.$**                                                                                                        |   | **U.S.$**                                                                                                         |   |
| **Sales:**                                                    |   |                                                                                                             |         |                                                                                                             |   |                                                                                                              |   |
| Income                                                        |   |                                                                                                             | --           |                                                                                                             |   | --                                                                                                                |   |   | 34,616 |   |
| Expenses                                                      |   |                                                                                                             |    |                                                                                                             |   |                                                                                                         |   |   |    |   |
|                                                          |   |                                                                                                             |         |                                                                                                             |   |                                                                                                              |   |   |   |   |
| Selling,                        general and administrative    |   |                                                                                                             | 2,064        |                                                                                                             |   | 76,892                                                                                                            |   |   | 2,370,722 |   |
| Amortization                                                  |   |                                                                                                             | 1,100        |                                                                                                             |   | --                                                                                                                |   |   | 4,822 |   |
|                                                          |   |                                                                                                             |         |                                                                                                             |   |                                                                                                              |   |   |   |   |
| Loss                        before Provision for Income Taxes |   |                                                                                                             | (3,164       | )                                                                                                                |   | (76,892                                                                                                           | )      |   | (2,340,928 | ) |
|                                                          |   |                                                                                                             |         |                                                                                                             |   |                                                                                                              |   |   |   |   |
| Provision                        for Income Taxes             |   |                                                                                                             |         |                                                                                                             |   |                                                                                                              |   |   |   |   |
| Comprehensive                        Net (Loss)               |   |                                                                                                             | (3,164       | )                                                                                                                |   | (76,892                                                                                                           | )      |   | (2,340,928 | ) |
|                                                          |   |                                                                                                             |         |                                                                                                             |   |                                                                                                              |   |   |   |   |
| Net                        Loss Per Common Share              |   |                                                                                                             | (0.00        | )                                                                                                                |   | (0.00                                                                                                             | )      |   | (0.01 | ) |
| Fully                        Diluted                          |   |                                                                                                             | (0.00        | )                                                                                                                |   | (0.00                                                                                                             | )      |   | (0.01 | ) |
| Weighted                        Average Common Shares         |   |                                                                                                             |         |                                                                                                             |   |                                                                                                              |   |   |   |   |
| Outstanding                                                   |   |                                                                                                             | 337,865,401  |                                                                                                             |   | 140,395,401                                                                                                       |   |   | 337,865,401 |   |
| Fully                        Weighted Average Common          |   |                                                                                                             |         |                                                                                                             |   |                                                                                                              |   |   |   |   |
| Shares                        Outstanding                     |   |                                                                                                             | 353,905,735  |                                                                                                             |   | 156,435,735                                                                                                       |   |   | 353,905,735 |   |

----

**BIO          TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION) AND          SUBSIDIARY**

**(A          DEVELOPMENT STAGE COMPANY)**

**CONSOLIDATED          INTERIM STATEMENTS OF STOCKHOLDERS’ DEFICIENCY**

**FOR          THE PERIOD FROM OCTOBER 19, 2000 TO DECEMBER 31, 2004**

**(UNAUDITED)**

|   |   | Shares |                                      | US$CommonStockAmount |                                      | US$AdditionalPaid-N-Capital |                                      | US$AccumulatedDeficitDuringDevelopmentState |                                      | US$TotalStockholdersDeficiencies |                                                               |
|--------|--------|--------|--------------------------------------------------------------------|----------------------|--------------------------------------------------------------------|-----------------------------|--------------------------------------------------------------------|---------------------------------------------|--------------------------------------------------------------------|----------------------------------|---------------------------------------------------------------------------------------------|

| Balance                        June 30, 2004                                                                |   |   | 337,865,401 |   |   | 337,866 |   |   | 6,815,147 |   |   | (2,282,975 | ) |   | 4,870,038 |   |
|-------------------------------------------------------------------------------------------------------------|--------|--------|-------------|--------|--------|---------|--------|--------|-----------|--------|--------|------------|---|--------|-----------|--------|
| Loss                            for the Period July 1, 2004 to December 31,                            2004 |   |   | --          |   |   | --      |   |   | --        |   |   | (57,863    | ) |   | (57,863   | )      |
|                                                                                                        |
|                                                                                                        |   |   | 337,865,401 |   |   | 337,866 |   |   | 6,815,147 |   |   | (2,340,838 | ) |   | 4,812,175 |   |

----

**BIO          TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION) AND          SUBSIDIARY**

**(A          DEVELOPMENT STAGE COMPANY)**

**CONSOLIDATED          INTERIM STATEMENTS OF CASH FLOWS**

|        |   | FOR                        THE PERIODOCT.                        1, 2004DECEMBER                        31, 2004 |   | FOR                        THE PERIODOCT.                        1, 2003DECEMBER                        31, 2003 |   | FOR                        THE PERIODOCT.                        19, 2000DECEMBER                        31, 2004 |   |
|--------|--------|------------------------------------------------------------------------------------------------------------------|--------|------------------------------------------------------------------------------------------------------------------|--------|-------------------------------------------------------------------------------------------------------------------|--------|
|   |   | **U.S.$**                                                                                                        |   | **U.S.$**                                                                                                        |   | **U.S.$**                                                                                                         |   |

| **Cash                      Flows from Operating Activities:**                                                                |   |   |     |       |       |         |       |
|-------------------------------------------------------------------------------------------------------------------------------|--------|--------|----------|------------|------------|--------------|------------|
| Net                      Loss                                                                                                 |   |   | (3,164   | )          |       | (76,892      | )          |   | (2,340,828 | ) |
| Adjustments                      to reconcile net loss to net                                                                 |   |   |     |       |       |         |       |   |   |   |
| Cash                      provided by (used in) operating activities                                                          |   |   | --       |       |       | --           |       |   | -- |   |
| Depreciation                      and amortization                                                                            |   |   | 1,100    |       |       | --           |       |   | 37,572 |   |
| (Increase)                      decrease in:                                                                                  |   |   | --       |       |       | --           |       |   | -- |   |
| R&D                      refundable tax credit                                                                            |   |   | --       |       |       | (212,308     | )          |   | (212,308 | ) |
| Sales                      tax receivable                                                                                     |   |   | --       |       |       | (6,388       | )          |   |   |   |
| Accounts                      payable                                                                                         |   |   | --       |       |       | (2,513       | )          |   | 85,000 |   |
| Amounts                      due to officers                                                                                  |   |   | --       |       |       | (305,559     | )          |   | 98,274 |   |
| Amounts                      due officers and Employees                                                                       |   |   | 1,925    |       |       | --           |       |   | -- |   |
| Loss                      on disposal of assets                                                                               |   |   | --       |       |       | --           |       |   | 121,563 |   |
|                                                                                                                          |
| **Net                        Cash and Cash Equivalents Provided by****(Used in) Operating                        Activities** |   |   | **(139** | **)**      | ** ** | **(603,660** | **)**      | ** ** | **(2,210,727** | **)** |
|                                                                                                                          |
| **Cash                      Flows from Investing Activities**                                                                 |   |   |     |       |       |         |       |   |   |   |
| Purchase                      of Goodwill                                                                                     |   |   | --       |       |       | (200,000     | )          |   | (4,762,020 | ) |
| Purchase                      of Capital Assets                                                                               |   |   | --       |       |       | (25,672      | )          |   | (211,070 | ) |
|                                                                                                                          |
| **Net                      Cash Used for Investing Activities**                                                               |   |   | **--**   | ** ** | ** ** | **(225,672** | **)**      | ** ** | **(4,973,090** | **)** |
|                                                                                                                          |
| **Cash                      Flows from Financing Activities:**                                                                |   |   |     |       |       |         |       |   |   |   |
| Write-off                      deficit to Paid-in-Capital                                                                     |   |   | --       |       |       | --           |       |   | 139,877 |   |
| Write-off                      comprehensive income to Paid Capital                                                           |   |   | --       |       |       | --           |       |   | 10,807 |   |
| Write-off                      stock subscription receivable                                                                  |   |   | --       |       |       | --           |       |   | 196,349 |   |
| Decrease                      in short term loans                                                                             |   |   | --       |       |       | (194,788     | )          |   | -- |   |
|  (Decrease)                      Increase in loans payable                                                               |   |   | --       |       |       | 868,579      |       |   | -- |   |
| Increase                      in capital stock                                                                                |   |   | --       |       |       | 24,493       |       |   | 221,963 |   |
| Increase                      in paid-in capital                                                                              |   |   | --       |       |       | 92,562       |       |   | 6,615,092 |   |
|                                                                                                                          |
| **Net                        Cash from Financing Activities**                                                                 |   |   | **--**   | ** ** | ** ** | **790,846**  | ** ** | ** ** | **7,184,088** |   |
|                                                                                                                          |
| Net                      (Decrease) Increase in Cash                                                                          |   |   | (139     | )          |       | (38,486      | )          |   | 271 |   |
| Cash                      - Beginning of Period                                                                               |   |   | 410      |       |       | 43,486       |       |   | -- |   |
|                                                                                                                          |
| Cash                      - End of Period                                                                                     |   |   | **271**  | ** ** | ** ** | **5,000**    | ** ** | ** ** | **271** |   |
|                                                                                                                          |
| **Supplemental                        Disclosure of Non-Cash Flow Information:**                                              |   |   |     |       |       |         |       |   |   |   |
| Cash                      paid during the Year for:                                                                           |   |   |     |       |       |         |       |   |   |   |
| Interest                                                                                                                      |   |   | --       |       |       | --           |       |   | -- |   |
| Income                      Taxes                                                                                             |   |   | --       |       |       | --           |       |   | -- |   |
|                                                                                                                          |   |   |     |       |       |         |       |   |   |   |
|                                                                                                                          |   |   | --       |       |       | --           |       |   | -- |   |

----

**BIO          TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION) AND          SUBSIDIARY**

**(A          DEVELOPMENT STAGE COMPANY)**

**INTERIM          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**1.     **
**BACKGROUND          AND ORGANIZATION**

**2.    **
**ACCOUNTING          POLICIES**

**Basis        of Presentation**

**Principles          of Consolidation**

**Cash          and Cash Equivalent**

**Furniture,          Fixtures and Equipment**

----

**BIO            TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION)            AND            SUBSIDIARY**

**(A            DEVELOPMENT STAGE COMPANY)**

**INTERIM            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**Income          Taxes**

**Earnings          Per Share**

**Use          of Estimates**

**Fair          Value Disclosure at December 31, 2004**

**Effect          of New Accounting Standards**

----

**BIO            TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION)            AND            SUBSIDIARY**

**(A            DEVELOPMENT STAGE COMPANY)**

**INTERIM            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**Effect          of New Accounting Standards**

**3.    GOING          CONCERN**

**4.    PROVISION          FOR          INCOME TAX**

**5.    COMMITMENTS          AND CONTINGENCIES **

**Insurance**

**Contingencies**

**6.    REDUCTION          OF          LOAN OUTSTANDING**

----

**BIO            TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION)            AND            SUBSIDIARY**

**(A            DEVELOPMENT STAGE COMPANY)**

**INTERIM            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**7.    GOODWILL**

**8.    **SUBSEQUENT          EVENTS****

**Significant          Changes to Key Management and Share Capital Management          Changes**

----

**BIO            TRACKING SECURITY INC. (FORMERLY CHINA XIN NETWORK MEDIA CORPORATION)            AND            SUBSIDIARY**

**(A            DEVELOPMENT STAGE COMPANY)**

**INTERIM            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**Changes          in Share Capital**

----

**Item          2. Management's Discussion and Analysis of Financial Condition and Results          of          Operations**

*Statements          included in this Management's Discussion and Analysis of Financial Condition          and          Results of Operations, and in future filings by the company with the Securities          and Exchange Commission, in the company's press releases and in oral statements          made with the approval of an authorized executive officer which are not          historical nor current facts are "forward-looking statements" and are subject          to          certain risks and uncertainties that could cause actual results to differ          materially from historical earnings and those presently anticipated or          projected. Without limiting the generality of the foregoing, words such          as          "may,"  "will,"  "expect,"  "believe,"  "anticipate,"           "intend,"  "could,"  "estimate," or "continue" or the negative          or          other variations thereof or comparable terminology are intended to identify          forward-looking statements. The foregoing list should not be construed          as          exhaustive and the company disclaims any obligation subsequently to revise          any          forward-looking statements to reflect events or circumstances after the          date of          such statements or to reflect the occurrence of anticipated or unanticipated          events. You are cautioned not to place undue reliance on any such          forward-looking statements, which speak only as of the date made. The following          important factors, among others, in some cases have affected and in the          future          could affect the our actual results and could cause the our actual financial          performance to differ materially from that expressed in any forward-looking          statement: (i) the extremely competitive conditions that currently exist          in the          market for companies similar to us; (ii) lack or resources to maintain          the          company's good standing status and requisite filings with the Securities          and          Exchange Commission; (iii) history of operating losses and accumulated          deficit;          (iv) possible need for additional financing; and (v) other factors discussed          in          this report and the Company's other filings with the Securities and Exchange          Commission. The following discussion should be read in conjunction with          our          financial statements and their explanatory notes included in the          report.*

**Summary**

----

**Operations          **

**Capital          Needs **

**Results          of Operations**

|        |   | FOR                    THE PERIODOCT.                    1, 2004DECEMBER                    31, 2004 |   | FOR                    THE PERIODOCT.                    1, 2003DECEMBER                    31, 2003 |   | FOR                    THE PERIODOCT.                    19, 2000DECEMBER                    31, 2004 |   |
|--------|--------|------------------------------------------------------------------------------------------------------|--------|------------------------------------------------------------------------------------------------------|--------|-------------------------------------------------------------------------------------------------------|--------|
|   |   | **U.S.$**                                                                                            |   | **U.S.$**                                                                                            |   | **U.S.$**                                                                                             |   |

| **Sales:**                                                |   |   |   |   |   |         |   |
|-----------------------------------------------------------|--------|--------|--------|--------|--------|--------------|--------|
| Income                                                    |   |   | --     |   |   | --           |   |   | 34,616 |   |
| Expenses                                                  |   |   |   |   |   |    |   |   |    |   |
|                                                      |   |   |   |   |   |         |   |   |   |   |
| Selling,                    general and administrative    |   |   | 2,064  |   |   | 76,892       |   |   | 2,370,722 |   |
| Amortization                                              |   |   | 1,100  |   |   | --           |   |   | 4,822 |   |
|                                                      |   |   |   |   |   |         |   |   |   |   |
| Loss                    before Provision for Income Taxes |   |   | (3,164 | )      |   | (76,892      | )      |   | (2,340,928 | ) |
|                                                      |   |   |   |   |   |         |   |   |   |   |
| Provision                    for Income Taxes             |   |   |   |   |   |         |   |   |   |   |
| Comprehensive                    Net (Loss)               |   |   | (3,164 | )      |   | (76,892      | )      |   | (2,340,928 | ) |

**RISK          FACTORS **

**FACTORS          THAT COULD AFFECT FUTURE RESULTS **

----

**Liquidity          and Capital Resources**

**ACCOUNTING          POLICIES SUBJECT TO ESTIMATION AND JUDGMENT**

**ITEM          3. EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES**

----

**PART          II. OTHER INFORMATION**

**Item          1. Legal Proceedings**

**Item          2. **
**Unregistered          Sales of Equity Securities and Use of Proceeds **

**Item          3. Defaults upon Senior Securities**

**Item          4. Submission of Matters to a Vote of Security Holders**

**Item          5. Other Information**

**Item          6. Exhibits and Reports on Form 8-K**

**A.          Exhibits**

----

**SIGNATURES**

|                                          |                                                                                                                                    |                                            |
|-----------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------|
|                                          | **BIO-TRACKING                    SECURITY SYSTEMS, INC.**                                                                              |
|                                     |                                                                                                                               |                                       |
| Date: October                    6, 2005 | By:                                                                                                                           | /s/ Jean-Francois                    Amyot |
|                                          | Name:                     Jean-Francois Amyot                                                                                      |
|                                          | Title:                        Chief                      Executive Officer (Principal                      Executive Officer) |

|                                        |                                                                                                                                |                                          |
|---------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------|
| Date: October                  6, 2005 | By:                                                                                                                       | /s/ Jean-Francois                  Amyot |
|                                        | Name:                   Jean-Francois Amyot                                                                                    |
|                                        | Title:                      Chief                    Accounting Officer (Principal                    Accounting Officer) |

----